Company Filing History:
2 out of 228 
1 out of 15,528 
1 out of 62 
Years Active: 2021-2025
Title: **Helene Faustrup Kildegaard: Pioneering Innovator in Biopharmaceuticals**
Introduction
Helene Faustrup Kildegaard is an accomplished inventor based in Værløse, Denmark. With two valuable patents to her name, she has made significant contributions to the field of biopharmaceuticals. Her work focuses on enhancing the production processes of therapeutic proteins, making them more effective for clinical applications.
Latest Patents
One of Kildegaard's notable patents is titled "Glycosylation of Proteins." This invention addresses methods to manipulate the glycosylation profile of recombinant produced glycoproteins, shifting it toward the predominant bi-antennary form found in human plasma. By employing a specialized mammalian cell line with targeted gene disruptions and insertions, she has successfully achieved this critical shift.
Another significant patent is "Method for Reducing Ammonium and Lactate Production in CHO Cells." This innovation involves modified producer cells specifically designed to improve the yield and viability of therapeutic proteins. Kildegaard's research shows that removing genes responsible for amino acid catabolism in Chinese Hamster Ovary (CHO) cells leads to increased cell growth, ultimately enhancing the production of recombinant proteins.
Career Highlights
Helene Faustrup Kildegaard is currently associated with the Technical University of Denmark, where she conducts her research and develops her innovative biopharmaceutical methodologies. Her expertise has positioned her as a key figure in research and development efforts in her institution.
Collaborations
Throughout her career, Kildegaard has collaborated with esteemed colleagues, including Daniel Ley and Mikael Rørdam Andersen. These collaborations have fostered an environment of innovation and creativity, resulting in groundbreaking advancements in the biopharmaceutical field.
Conclusion
Helene Faustrup Kildegaard's innovative spirit and dedication to improving therapeutic protein production have solidified her status as an influential inventor in the biopharmaceutical industry. With her significant patents and collaborative efforts at the Technical University of Denmark, she continues to push the boundaries of what is possible in the realm of biotechnology.